EE348 Cost-Utility Analysis of Dapagliflozin in Patients with Chronic Kidney Disease in Costa Rica
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.596
https://www.valueinhealthjournal.com/article/S1098-3015(22)00797-5/fulltext
Title :
EE348 Cost-Utility Analysis of Dapagliflozin in Patients with Chronic Kidney Disease in Costa Rica
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00797-5&doi=10.1016/j.jval.2022.04.596
First page :
Section Title :
Open access? :
No
Section Order :
10533